| Detected | Trial | Change |
|---|---|---|
| 2026-07-30 | NCT07524140 A First-in-Human Study of ZE94-0605 in Patients With Advanced Solid Tumors |
Recruitment opened |
| 2026-07-30 | NCT07524140 A First-in-Human Study of ZE94-0605 in Patients With Advanced Solid Tumors |
Primary endpoint(s) modified |
| 2026-07-30 | NCT07524140 A First-in-Human Study of ZE94-0605 in Patients With Advanced Solid Tumors |
Trial sites expanded: 0 -> 3 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-30 | NCT07735728 A First-in-Human Study of ZE66-0205 in Healthy Volunteers | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1 | |||
| NCT07524140 | A First-in-Human Study of ZE94-0605 in Patients With Advanced Solid Tumors | Advanced Solid Tumor Cancer | Recruiting |
| NCT07529951 | Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers | Polycythemia Vera (PV) | Not Yet Recruiting |
| NCT07234864 | Study to Assess Safety, Tolerability, PK, and PD of Multiple Doses of ZE63-0302… | Type 2 Diabetes | Active, Not Recruiting |
| NCT07735728 | A First-in-Human Study of ZE66-0205 in Healthy Volunteers | Healthy Volunteers (HV) | Not Yet Recruiting |